BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32587478)

  • 1. β-catenin promotes MTX resistance of leukemia cells by down-regulating FPGS expression via NF-κB.
    Liu SG; Yue ZX; Li ZG; Zhang RD; Zheng HY; Zhao XX; Gao C
    Cancer Cell Int; 2020; 20():271. PubMed ID: 32587478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance.
    Wojtuszkiewicz A; Raz S; Stark M; Assaraf YG; Jansen G; Peters GJ; Sonneveld E; Kaspers GJ; Cloos J
    Int J Cancer; 2016 Apr; 138(7):1645-56. PubMed ID: 26547381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Expression and Activation of the NF-κB Pathway Correlate with Methotrexate Resistance and Cell Proliferation in Acute Lymphoblastic Leukemia.
    Canevarolo RR; Cury NM; Yunes JA
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.
    Rots MG; Pieters R; Peters GJ; Noordhuis P; van Zantwijk CH; Kaspers GJ; Hählen K; Creutzig U; Veerman AJ; Jansen G
    Blood; 1999 Mar; 93(5):1677-83. PubMed ID: 10029597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia.
    Stark M; Wichman C; Avivi I; Assaraf YG
    Blood; 2009 Apr; 113(18):4362-9. PubMed ID: 19131550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy.
    Leclerc GJ; Mou C; Leclerc GM; Mian AM; Barredo JC
    Leukemia; 2010 Mar; 24(3):552-62. PubMed ID: 20072153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
    McGuire JJ; Russell CA
    Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mbr-FPGS efficient expression plasmid enhances the sensitivity of Jurkat cells to methotrexate].
    Hu WJ; Sun YJ
    Yi Chuan; 2012 Jun; 34(6):705-10. PubMed ID: 22698741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method.
    Rots MG; Willey JC; Jansen G; Van Zantwijk CH; Noordhuis P; DeMuth JP; Kuiper E; Veerman AJ; Pieters R; Peters GJ
    Leukemia; 2000 Dec; 14(12):2166-75. PubMed ID: 11187907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of folylpoly-gamma-glutamate synthetase gene expression in human B-precursor ALL and T-lineage ALL cells.
    Leclerc GJ; Leclerc GM; Kinser TT; Barredo JC
    BMC Cancer; 2006 May; 6():132. PubMed ID: 16707018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Sensitive UHPLC-MS/MS-Based Method for the Analysis of Folylpolyglutamate Synthetase Enzymatic Activity in Peripheral Blood Mononuclear Cells: Application in Rheumatoid Arthritis and Leukemia Patients.
    Muller IB; Lin M; Struys EA; Heydari P; Hebing RCF; Nurmohamed MT; van der Laken C; Lems WF; Cloos J; Jansen G; de Jonge R
    Ther Drug Monit; 2019 Oct; 41(5):598-606. PubMed ID: 31008996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted expression of human folylpolyglutamate synthase for selective enhancement of methotrexate chemotherapy in osteosarcoma cells.
    Bienemann K; Staege MS; Howe SJ; Sena-Esteves M; Hanenberg H; Kramm CM
    Cancer Gene Ther; 2013 Sep; 20(9):514-20. PubMed ID: 23949282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
    Jin B; Wang C; Li J; Du X; Ding K; Pan J
    Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells.
    Panetta JC; Sparreboom A; Pui CH; Relling MV; Evans WE
    PLoS Comput Biol; 2010 Dec; 6(12):e1001019. PubMed ID: 21152005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia.
    Barredo JC; Synold TW; Laver J; Relling MV; Pui CH; Priest DG; Evans WE
    Blood; 1994 Jul; 84(2):564-9. PubMed ID: 7517720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Intracellular Metabolism of Methotrexate in Hepatocytes and Embryonic Kidney Cells based on Folylpolyglutamate Synthetase and Gamma-Glutamyl Hydrolase Expression.
    Jiang H; Yang J; Hou Y; Zhang K; Ren Y; Huang J; Li H; Cai T; Ouyang Z; Zhao J; Yu P
    Curr Drug Metab; 2023; 24(2):139-147. PubMed ID: 37038713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
    Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
    Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-resistance studies of folylpolyglutamate synthetase-deficient, methotrexate-resistant CCRF-CEM human leukemia sublines.
    McGuire JJ; Heitzman KJ; Haile WH; Russell CA; McCloskey DE; Piper JR
    Leukemia; 1993 Dec; 7(12):1996-2003. PubMed ID: 8255099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of polyglutamylation of methotrexate on its accumulation and the development of resistance in the protozoan parasite Leishmania.
    El-Fadili A; Richard D; Kündig C; Ouellette M
    Biochem Pharmacol; 2003 Sep; 66(6):999-1008. PubMed ID: 12963486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytosolic and mitochondrial folylpolyglutamate synthetase are electrophoretically distinct. Expression in antifolate-sensitive and -resistant human cell lines.
    McGuire JJ; Russell CA; Balinska M
    J Biol Chem; 2000 Apr; 275(17):13012-6. PubMed ID: 10777604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.